MarketScreener Strategies Regeneron Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-09 pm EDT			5-day change	1st Jan Change
767.85 ^USD	-0.99%		+0.79%	-0.52%

Apr. 08	Bernstein Adjusts Regeneron Pharmaceuticals Price Target to $921 From $925, Maintains Outperform Rating	MT
Apr. 08	Regeneron Expects $0.81 per Share Net Income Impact From $102 Million R&D Charges for Q1	MT

No results for this search

Regeneron's Yancopoulos on Hearing Loss Gene Therapy, Weight Loss Drugs

January 13, 2026 at 04:08 pm EST